Dr. Curtiland Deville is an Associate Professor in the Department of Radiation Oncology and Molecular Radiation Sciences at the Johns Hopkins University School of Medicine. He serves as Medical Director of the Johns Hopkins Proton Therapy Center and Clinical Director and Chair of Sibley Radiation Oncology.

Dr. Deville’s clinical expertise involves treating patients with prostate cancer and soft tissue sarcoma. His funded research interests include improving tumor targeting and assessing toxicity profiles using modern radiation techniques such as proton therapy. He has co-authored over 150 peer-reviewed publications and serves as a Deputy Editor for the International Journal of Radiation Oncology, Biology, Physics.

Dr. Deville has a research interest in physician workforce diversity as a means to address health equity. He is a leading voice in health equity, diversity, and inclusion (HEDI) in Radiation Oncology. He led the formation of the American Society for Radiation Oncology’s (ASTRO) Council on HEDI and was recently elected to the ASTRO Board of Directors.